Claudio Bonifati Selected Research

Immunosuppressive Agents (Immunosuppressants)

4/2015

Unusual case of B cell lymphoma after immunosuppressive treatment for psoriasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Claudio Bonifati Research Topics

Disease

18	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2024 - 04/2015
7	Psoriatic Arthritis 04/2024 - 01/2014
3	Arthritis (Polyarthritis) 01/2019 - 01/2014
2	Pain (Aches) 01/2019 - 01/2014
2	Infections 01/2019 - 07/2016
2	Hepatitis B 01/2019 - 07/2016
2	Skin Diseases (Skin Disease) 12/2017 - 12/2016
1	COVID-19 01/2022
1	Obesity 07/2021
1	Familial pityriasis rubra pilaris 07/2020
1	Mixed Connective Tissue Disease (MCTD) 06/2020
1	Substance-Related Disorders (Drug Abuse) 05/2019
1	Papilloma (Papillomatosis) 12/2018
1	Parakeratosis 12/2018
1	Pityriasis Rubra Pilaris 01/2018
1	Persistent Infection 07/2016
1	Chemical and Drug Induced Liver Injury 04/2015
1	Lymphoma (Lymphomas) 04/2015
1	Necrosis 04/2015
1	Inflammation (Inflammations) 01/2014
1	Pruritus (Itching) 01/2014

Drug/Important Bio-Agent (IBA)

4	secukinumabIBA 01/2023 - 05/2019
4	Adalimumab (Humira)FDA Link 01/2021 - 01/2014
4	Etanercept (Enbrel)FDA Link 01/2018 - 01/2014
3	Prostaglandins AIBA 12/2024 - 01/2019
3	Interleukin-23 (Interleukin 23)IBA 12/2024 - 01/2021
3	Acitretin FDA Link 01/2021 - 07/2016
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 04/2015
2	risankizumabIBA 04/2024 - 01/2022
2	ixekizumabIBA 01/2021 - 01/2019
2	brodalumabIBA 01/2021 - 07/2020
2	ametantrone (HAQ)IBA 01/2019 - 01/2014
2	Ustekinumab (CNTO 1275)FDA Link 07/2016 - 05/2016
2	Infliximab (Remicade)FDA Link 07/2016 - 04/2015
1	tildrakizumabIBA 12/2024
1	guselkumabIBA 12/2022
1	BNT162 VaccineIBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Immunomodulating AgentsIBA 01/2022
1	VaccinesIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2021
1	apremilastIBA 06/2020
1	Imiquimod (Aldara)FDA LinkGeneric 12/2018
1	Cellular Retinol-Binding ProteinsIBA 12/2018
1	golimumab FDA Link 12/2017
1	Matrix Metalloproteinases (MMPs)IBA 12/2016
1	RNA (Ribonucleic Acid)IBA 07/2016
1	AlbuminsIBA 07/2016
1	Alkaline PhosphataseIBA 07/2016
1	Transaminases (Aminotransferases)IBA 07/2016
1	Antiviral Agents (Antivirals)IBA 07/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2016
1	BilirubinIBA 07/2016
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 07/2016
1	TransferasesIBA 07/2016
1	efalizumab (Raptiva)FDA Link 04/2015
1	Methotrexate (Mexate)FDA LinkGeneric 04/2015
1	Immunosuppressive Agents (Immunosuppressants)IBA 04/2015
1	Alefacept (Amevive)FDA Link 04/2015

Therapy/Procedure

8	Therapeutics 07/2021 - 01/2014
2	Phototherapy (Light Therapy) 01/2021 - 07/2016
1	Liver Transplantation 01/2019